| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
32,104 |
28,671 |
$2.01M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,331 |
4,984 |
$1.25M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,933 |
6,628 |
$1.06M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,619 |
2,428 |
$940K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,361 |
3,020 |
$397K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,022 |
3,164 |
$316K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,150 |
1,106 |
$247K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,680 |
2,676 |
$158K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,566 |
2,990 |
$158K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,560 |
2,496 |
$149K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,345 |
1,128 |
$141K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,745 |
2,344 |
$114K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
865 |
827 |
$112K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,145 |
1,123 |
$106K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
5,489 |
2,013 |
$105K |
| 71045 |
Radiologic examination, chest; single view |
1,886 |
1,793 |
$93K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,467 |
1,444 |
$84K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,384 |
2,305 |
$78K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,589 |
1,587 |
$77K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,846 |
724 |
$73K |
| G0378 |
Hospital observation service, per hour |
457 |
307 |
$57K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
509 |
497 |
$50K |
| 97161 |
|
578 |
565 |
$36K |
| 71046 |
Radiologic examination, chest; 2 views |
851 |
789 |
$34K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
600 |
599 |
$33K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
729 |
328 |
$27K |
| Q3014 |
Telehealth originating site facility fee |
1,321 |
1,261 |
$27K |
| 70450 |
Computed tomography, head or brain; without contrast material |
329 |
313 |
$27K |
| 80061 |
Lipid panel |
1,785 |
1,771 |
$23K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
348 |
348 |
$21K |
| 80053 |
Comprehensive metabolic panel |
10,157 |
9,024 |
$19K |
| 97162 |
|
392 |
387 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,760 |
3,614 |
$18K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,516 |
1,495 |
$18K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
173 |
171 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,518 |
11,670 |
$16K |
| 86900 |
|
392 |
375 |
$13K |
| 76830 |
Ultrasound, transvaginal |
126 |
125 |
$10K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
158 |
158 |
$9K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
971 |
967 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,734 |
1,548 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,724 |
2,551 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,258 |
2,219 |
$8K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
112 |
112 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,669 |
1,646 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
10,044 |
8,554 |
$5K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
68 |
68 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
30 |
30 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,431 |
2,331 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
108 |
108 |
$4K |
| 87088 |
|
2,319 |
2,222 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
722 |
705 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
289 |
235 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,838 |
2,526 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
208 |
206 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
36 |
36 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
51 |
40 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
153 |
153 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
230 |
230 |
$2K |
| 97035 |
|
320 |
125 |
$2K |
| 82947 |
|
13 |
12 |
$2K |
| 81001 |
|
6,866 |
6,273 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
197 |
194 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
30 |
27 |
$1K |
| 83735 |
|
5,931 |
5,086 |
$898.02 |
| 73564 |
|
25 |
25 |
$679.49 |
| 86780 |
|
52 |
52 |
$532.78 |
| 85610 |
|
1,001 |
902 |
$527.24 |
| 86140 |
|
614 |
589 |
$519.07 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,396 |
1,216 |
$474.30 |
| 83690 |
|
2,847 |
2,597 |
$419.66 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
480 |
472 |
$414.30 |
| 87081 |
|
373 |
368 |
$399.91 |
| 73630 |
|
85 |
80 |
$383.05 |
| 87400 |
|
1,033 |
997 |
$364.41 |
| 85652 |
|
659 |
632 |
$324.94 |
| 86803 |
|
61 |
61 |
$272.52 |
| 81025 |
|
2,420 |
2,274 |
$265.78 |
| 73030 |
|
41 |
37 |
$246.98 |
| 84439 |
|
57 |
57 |
$244.07 |
| 87510 |
|
40 |
40 |
$237.82 |
| 87480 |
|
40 |
40 |
$237.82 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
542 |
534 |
$230.73 |
| 87660 |
|
40 |
40 |
$223.02 |
| 82728 |
|
56 |
56 |
$218.28 |
| 87420 |
|
248 |
239 |
$205.89 |
| 87071 |
|
146 |
144 |
$202.26 |
| 87186 |
|
104 |
100 |
$184.62 |
| 80306 |
|
1,418 |
1,284 |
$176.87 |
| 82607 |
|
42 |
42 |
$175.10 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$169.27 |
| 73610 |
|
45 |
45 |
$153.45 |
| 87077 |
|
102 |
98 |
$131.82 |
| 87070 |
|
110 |
106 |
$127.06 |
| 87340 |
|
28 |
28 |
$118.97 |
| 82248 |
|
1,552 |
1,468 |
$110.07 |
| 83880 |
|
56 |
52 |
$88.17 |
| 86762 |
|
14 |
14 |
$80.54 |
| 84484 |
|
1,391 |
1,268 |
$63.21 |
| 83605 |
|
1,182 |
1,082 |
$56.16 |
| 85730 |
|
343 |
332 |
$55.65 |
| 86850 |
|
231 |
221 |
$46.19 |
| 84702 |
|
15 |
13 |
$33.33 |
| 85379 |
|
185 |
185 |
$31.46 |
| 82043 |
|
12 |
12 |
$27.90 |
| 84703 |
|
274 |
264 |
$27.34 |
| 80076 |
|
54 |
53 |
$22.25 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
6,217 |
4,602 |
$20.94 |
| 82948 |
|
335 |
244 |
$11.97 |
| 82746 |
|
12 |
12 |
$10.85 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,143 |
2,827 |
$5.68 |
| 82150 |
|
56 |
50 |
$4.07 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,345 |
2,917 |
$0.05 |
| 80143 |
|
209 |
191 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
234 |
228 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
171 |
147 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
105 |
93 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
15 |
14 |
$0.00 |
| 94642 |
|
14 |
13 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
12 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
1,979 |
1,898 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
427 |
394 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
489 |
415 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,739 |
1,678 |
$0.00 |
| A9900 |
Miscellaneous dme supply, accessory, and/or service component of another hcpcs code |
27 |
27 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,537 |
1,431 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
42 |
36 |
$0.00 |
| J3490 |
Unclassified drugs |
272 |
222 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
91 |
79 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,557 |
1,476 |
$0.00 |
| A9270 |
Non-covered item or service |
290 |
96 |
$0.00 |
| J1094 |
Injection, dexamethasone acetate, 1 mg |
167 |
162 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
90 |
78 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
126 |
115 |
$0.00 |
| 96376 |
|
44 |
27 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
12 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
31 |
27 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
13 |
13 |
$0.00 |